Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
amgen
3
×
biotech
clinical trials
drugs
3
×
life sciences
3
×
national blog main
boston blog main
calcitonin gene-related peptide
eli lilly
fda
indiana blog main
indiana top stories
migraine
new york blog main
new york top stories
svb leerink
teva pharmaceutical
alder biopharmaceutical
alirocumab
allergan
alnylam pharmaceuticals
american academy of neurology
atogepant
biohaven
bob azelby
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
chronic migraine
detroit blog main
detroit top stories
episodic migraine
eptinezumab
erenumab
evercore isi
evolocumab
fremanezumab
galcanezumab
What
drug
new
3
×
approval
class
fda
medicines
migraine
won
alnylam
announced
approved
arguments
based
big
cholesterol
commercialized
companies
competitors
data
decades
decision
developed
drugs
eli
evidence
headache
heart
lasting
late
lilly
long
looms
lowering
make
marks
medco
meeting
neuro
oral
pain
Language
Current search:
new
×
photo
×
" life sciences "
×
drugs
×
amgen
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines